Baron Opportunity Fund Institutional Class
BIOIX
NASDAQ
| Weiss Ratings | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Company Info | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Baron Capital Group, Inc. | |||
| Manager/Tenure (Years) | Michael Lippert (19) | |||
| Website | http://www.BaronFunds.com/performance | |||
| Fund Information | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Baron Opportunity Fund Institutional Class | |||
| Category | Large Growth | |||
| Sub-Category | US Equity Large Cap Growth | |||
| Prospectus Objective | Growth | |||
| Inception Date | May 29, 2009 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.27% | |||
| Asset Allocation | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.27% | |||
| Stock | 97.12% | |||
| U.S. Stock | 88.61% | |||
| Non-U.S. Stock | 8.51% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 2.61% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.83% | |||
| 30-Day Total Return | 20.93% | |||
| 60-Day Total Return | 11.69% | |||
| 90-Day Total Return | -4.85% | |||
| Year to Date Total Return | 1.40% | |||
| 1-Year Total Return | 25.66% | |||
| 2-Year Total Return | 72.20% | |||
| 3-Year Total Return | 92.48% | |||
| 5-Year Total Return | 122.76% | |||
| Price | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | -- | |||
| 1-Month Low NAV | $41.06 | |||
| 1-Month High NAV | $51.12 | |||
| 52-Week Low NAV | $39.63 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $55.37 | |||
| 52-Week High Price (Date) | Dec 16, 2024 | |||
| Beta / Standard Deviation | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.12 | |||
| Standard Deviation | 22.28 | |||
| Balance Sheet | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.38B | |||
| Operating Ratios | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.05% | |||
| Turnover Ratio | 33.00% | |||
| Performance | BIOIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 28.41% | |||
| Last Bear Market Total Return | -26.95% | |||